Veterinary Rapid Test Market Report 2026

The veterinary rapid test market size has grown rapidly in recent years. It will grow from $0.89 billion in 2025 to $0.99 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to outbreaks of infectious diseases in animals, need for faster diagnosis compared to traditional lab testing, growth in companion and production animal populations, limited access to centralized diagnostic laboratories, increasing awareness of zoonotic diseases.

The veterinary rapid test market size is expected to see rapid growth in the next few years. It will grow to $1.46 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to advancements in molecular and immunoassay technologies, rising demand for on-site diagnostic solutions, expansion of livestock farming and intensive animal production, increasing focus on early disease detection, growing investment in veterinary diagnostics innovation. Major trends in the forecast period include growing demand for point-of-care diagnostics, rising adoption of rapid tests for infectious disease screening, increasing use of portable and handheld diagnostic devices, expansion of preventive and routine animal health testing, preference for user-friendly and time-efficient diagnostic solutions.

The increasing level of pet ownership is expected to propel the growth of the veterinary rapid test market in the coming years. Pet ownership refers to the relationship in which an individual or household assumes responsibility for the care, welfare, and maintenance of a pet animal. The rise in pet ownership is driven by growing awareness of the mental health benefits pets offer, including stress reduction and companionship. Higher pet ownership supports the adoption of veterinary rapid testing by increasing demand for frequent, convenient, and early diagnostic screening, as more pet owners seek timely, affordable, and preventive healthcare solutions to ensure their animals’ health and well-being. For example, in April 2025, according to the Canadian Animal Health Institute, a Canada-based trade association, Canada was home to an estimated 7.2 million dogs and 8.2 million cats in 2024, with pets forming an essential part of more than half of Canadian households. Therefore, rising pet ownership is driving the veterinary rapid test market.

Major companies operating in the veterinary rapid test market are focusing on the development of advanced solutions, such as AI-based rapid tests, to improve diagnostic accuracy and enhance overall efficiency in veterinary healthcare. AI-based rapid tests represent a major advancement in veterinary diagnostics by enabling faster testing, more accurate results, and improved decision-making, ultimately elevating the quality of animal care. For instance, in November 2023, Micron Agritech, an Ireland-based sustainable health company, launched the Micron Kit Fluke Test, an AI-powered rapid diagnostic solution for liver fluke detection in livestock. This innovative test allows farmers and veterinarians to perform on-site testing using smartphones to identify both liver fluke (Fasciola hepatica) and rumen fluke (Calicophoron daubneyi) infections.

In September 2023, Mars Incorporated, a U.S.-based multinational manufacturing and animal care company, acquired SYNLAB Vet for an undisclosed amount. Through this acquisition, Mars aimed to strengthen and expand its veterinary diagnostics and technology capabilities across Europe, increase its research and development presence, and improve access to pet healthcare solutions for veterinary professionals and pet owners. SYNLAB Vet is a Germany-based healthcare technology company specializing in advanced veterinary laboratory diagnostic services and comprehensive diagnostic technologies for veterinary clinics and professionals throughout Europe.

Major companies operating in the veterinary rapid test market are Thermo Fisher Scientific Inc., Zoetis Inc., bioMérieux SA, IDEXX Laboratories Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN GmbH, Virbac Corp., Neogen Corporation, Antech Diagnostics Inc., Heska Corporation, Ring Biotechnology Co Ltd., BioChek, Bionote USA Inc., Agrolabo S.p.A., Shenzhen Bioeasy Biotechnology Co. Ltd., Fassisi GmbH, MEGACOR Diagnostik GmbH, Biopanda Reagents Ltd., Boster Biological Technology Co. Ltd., Secure Diagnostics Pvt. Ltd., Eurolyser Diagnostica GmbH.

North America was the largest region in the veterinary rapid test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary rapid test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary rapid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the veterinary rapid test market by increasing the cost of imported diagnostic kits, reagents, and test readers, affecting pricing and availability. Regions such as asia-pacific and north america are most affected due to reliance on imported molecular diagnostics and components. Segments including pcr-based rapid tests and portable readers have faced higher cost pressures, while tariffs have also encouraged local manufacturing, regional sourcing, and development of cost-effective rapid diagnostic solutions. Overall, tariffs have driven supply chain diversification and domestic production initiatives.

The veterinary rapid test market research report is one of a series of new reports that provides veterinary rapid test market statistics, including veterinary rapid test industry global market size, regional shares, competitors with a veterinary rapid test market share, detailed veterinary rapid test market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary rapid test industry. This veterinary rapid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A veterinary rapid test serves as a diagnostic instrument utilized in veterinary medicine to swiftly identify specific pathogens, diseases, or conditions in animals. These tests are engineered to deliver rapid and precise results, often within minutes to a few hours, facilitating prompt decision-making in the treatment and management of animal health. Veterinary rapid tests play a pivotal role in animal healthcare by facilitating early diagnosis and treatment, enhancing outcomes, and aiding in the control and prevention of disease transmission within animal populations.

The primary product categories of veterinary rapid tests include rapid test kits and rapid test readers. Veterinary rapid test kits are specialized devices employed for screening animals such as cats, dogs, cattle, and bovines, by analyzing a specimen sample placed on the device. These tests cater to various animal types including companion animals and production animals, utilizing diverse technologies such as immunoassays and polymerase chain reaction (PCR). They are utilized across a spectrum of applications encompassing viral diseases, bacterial diseases, parasitic diseases, allergies, among others, and are employed by diverse end-users including veterinary hospitals and clinics, home care settings, among others.

The veterinary rapid test market consists of sales of canine tests, feline tests, equine tests, and livestock tests. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.